Fellowship Directors' Section Education & Training Committee - Financial Interest Disclosures

Disclosures

ASRS adheres to the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The individuals below have responded that they have no relevant financial relationships with ineligible entities:

Planning Committee Members:

Christopher D. Conrady, MD, PhD  

Steven D. Ness, MD

Bradley T. Smith, MD, FASRS

Merina Thomas, MD

Sami H. Uwaydat, MD                  

The individuals below have disclosed the following financial relationships with ineligible entities:

 Planning Committee Members: Name of Ineligible Company/Nature of Relationship

Mark P. Breazzano, MD, FACS: Iveric Bio_Astellas/Advisory Board Member; Iveric Bio_Astellas/Speaker Bureau; ONL Therapeutics/Consultant

Vaidehi S. Dedania, MD: 4DMT/Advisory Board Member; Abbvie/Advisory Board Member; Abbvie/Consultant; Alimera/Advisory Board Member; Eyepoint Pharmaceuticals/Advisory Board Member; Iveric Bio/Advisory Board Member; ONL Therapeutics

Mrinali Gupta, MD, FASRS: Abbvie/Advisory Board Member; Alcon/Consultant; Alimera/Advisory Board Member; Carl Zeiss/Advisory Board Member

Talia R. Kaden, MD: 4DMT/ Advisory Board Member; Abbvie/Advisory Board Member; Alcon/Consultant; Alimera/Advisory Board Member; Apellis/Advisory Board Member; Eyepoint/Advisory Board Member; Genentech/Advisory Board Member; Regeneron/Advisory Board Member

Michelle C. Liang, MD, FASRS: Genentech/Advisory Board Member

Alexander Melamud, MD, MA: Alkeus Pharmaceuticals/Consultant; Eyepoint Pharmaceuticals/Advisory Board Member

Alexis Warren, MD: Abbvie/Advisory Board Member; Eyepoint/Consultant

Yoshihiro Yonekawa, MD, FASRS: Alcon/Consultant; Bausch & Lomb; Consultant; Eyebio/Principal or Named Investigator; Genentech/Consultant; Genentech/Principal or Named Investigator; Kyowa-Kirin/Principal or Named Investigator; Long Bridge Medical/Advisory Board Member; Ocugen/Principal or Named Investigator; Regeneron/Principal or Named Investigator; Versant Health/Advisory Board Member

Yuxi Zheng, MD: Apellis/Consultant